BRUSSELS, BELGIUM / RankWire.AI / – The European Commission has committed to purchasing €2.1 million worth of PCR tests to support the ongoing Bundibugyo Ebola outbreak response. These open-platform diagnostics aim to enhance infection detection capabilities and bolster laboratory infrastructure during this emergency. The procurement was coordinated with assistance from the European Health and Digital Executive Agency, with deliveries set to commence in August to supplement diagnostic supplies as health authorities contend with increasing case numbers in the Democratic Republic of the Congo.
These PCR testing kits will be delivered to the World Health Organization’s Logistics Hub for Global Health Emergencies in Dubai, which will oversee their distribution to Ebola-affected regions. PCR testing remains vital for confirming infections, as laboratories can analyze numerous samples swiftly and with high precision. The compatibility with existing laboratory systems ensures rapid deployment. Accurate and quick diagnosis supports health teams in identifying infected individuals, arranging suitable care and isolation measures, and conducting contact tracing around confirmed cases.
This initiative follows a separate €2.5 million agreement from the European Commission for rapid molecular point-of-care tests and testing devices, which will aid the Africa Centres for Disease Control and Prevention. Collectively, these efforts amount to €4.6 million in diagnostic support from the European Union. These actions form part of a broader European strategy to address the Bundibugyo virus crisis, which continues to strain healthcare systems across parts of Central and East Africa.
Testing capacity expands as outbreak intensifies
By August 12, WHO had reported 4,665 confirmed Ebola cases and 2,184 deaths in the Democratic Republic of the Congo. The outbreak has affected 54 health zones across six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO characterized it as the largest Ebola epidemic ever documented within the country. The organization also highlighted ongoing intense transmission, with interconnected geographic clusters facilitating continued spread within affected regions.
On August 14, WHO maintained its highest risk level for the Democratic Republic of the Congo, while rating the regional risk for neighboring nations as high and other regions as low. Following a second meeting of the International Health Regulations Emergency Committee on August 24, WHO issued updated temporary guidelines. These recommendations encompass surveillance, case detection, infection prevention, clinical management, community engagement, and measures related to domestic movement and mass gatherings.
European support grows to €493 million for regional health efforts
The European Commission announced the mobilization of €493 million for emergency aid, vaccines, treatments, and health-security initiatives across the Great Lakes region and Uganda. European health agencies have also contributed to surveillance activities, laboratory work, and preparedness efforts during the outbreak. The European Centre for Disease Prevention and Control continues to classify the risk to Europe as very low, based on the low likelihood of sustained transmission and the need for direct contact with infectious body fluids.
The Bundibugyo outbreak remains classified as a public health emergency of international concern, a status declared by WHO on May 17. Unlike the more common Zaire ebolavirus, no approved vaccine or specific treatment exists for the Bundibugyo virus at this time. WHO emphasizes ongoing surveillance, rapid diagnostics, patient isolation, clinical care, infection prevention, and contact monitoring as critical response components. The recent European PCR procurement enhances laboratory capacity to support these efforts, with WHO and Africa CDC coordinating health operations alongside national authorities in affected and neighboring countries.